| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 5% | $485,572 | 63,308 | Armistice Capital, LLC | 30 Jun 2025 |
As of 30 Sep 2025, 10 institutional investors reported holding 156,980 shares of CERO THERAPEUTICS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (CERO). This represents 12% of the company’s total 1,268,697 outstanding shares.
The largest institutional shareholders of CERO THERAPEUTICS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (CERO) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Parallel Advisors, LLC | 9.5% | 121,000 | -45% | 0.01% | $615,890 |
| ARCH Venture Management, LLC | 1.8% | 22,389 | 0% | 0.02% | $113,960 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.81% | 10,244 | 0% | $52,142 | |
| Tower Research Capital LLC (TRC) | 0.1% | 1,299 | +90% | 0% | $6,612 |
| FNY Investment Advisers, LLC | 0.08% | 1,050 | 0% | 0% | $5,000 |
| CITIGROUP INC | 0.08% | 968 | 0% | $4,927 | |
| SBI Securities Co., Ltd. | 0% | 18 | 0% | 0% | $92 |
| UBS Group AG | 0% | 6 | -100% | 0% | $30 |
| JONES FINANCIAL COMPANIES LLLP | 0% | 3 | 0% | 0% | $16 |
| BANK OF AMERICA CORP /DE/ | 0% | 3 | +50% | 0% | $15 |